Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
21/01/202115:05GlobeNewswire Inc.SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine ProductsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
20/01/202116:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
20/01/202108:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/12/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Describes Planned Response to ZIMHI Complete Response LetterNASDAQ:ADMPAdamis Pharmaceuticals Corporation
24/11/202015:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/11/202005:45GlobeNewswire Inc.Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHINASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/11/202015:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/11/202015:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/11/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Third Quarter 2020 Results Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/10/202016:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/10/202016:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/09/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pricing of Public Offering of Common StockNASDAQ:ADMPAdamis Pharmaceuticals Corporation
17/09/202015:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
17/09/202015:05GlobeNewswire Inc.Adamis Pharmaceuticals Announces Proposed Public Offering of Common StockNASDAQ:ADMPAdamis Pharmaceuticals Corporation
03/09/202015:05GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on Annual Meeting of StockholdersNASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/08/202015:50Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/08/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on Annual Meeting of Stockholders and ProposalsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
17/08/202015:40GlobeNewswire Inc.Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/08/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Pre-IND Feedback from FDA Enabling Advancement of Tempol, a Novel Anti-Inflammatory and Anti...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
10/08/202015:22Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/08/202015:05GlobeNewswire Inc.Adamis Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price RequirementNASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/07/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on SYMJEPI ProductsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/06/202005:31Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/06/202005:30Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/06/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Publication of Pharmacokinetic model suggesting that higher doses of naloxone are needed for...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/06/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces License to Commercialize Tempol, a Novel Investigational Anti-inflammatory and Antioxidant D...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/05/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Publication of Pharmacokinetic study comparing ZIMHI to current 2 mg intramuscular dose of n...NASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/05/202015:35GlobeNewswire Inc.Adamis Pharmaceuticals Announces First Quarter 2020 Financial Results and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
18/05/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDANASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/05/202008:00GlobeNewswire Inc.Adamis Pharmaceuticals Schedules First Quarter 2020 Earnings Conference Call and Business UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP